Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers

Total article views   Abstract views HTML views PDF downloads Totals
2,401 Dovepress* 1,796 299+ 340 2,095
PubMed Central* 0 306 89 306
Totals 1,796 605 429 2,401
*Since 18 October 2018
+Since July 2016

View citations on PubMed Central and Google Scholar